Stocks and Finance

MediciNova

MediciNova 5/24/2012

12:01 : MediciNova dives on asthma study results - BOSTON (MarketWatch) -- Shares of MediciNova Inc. dove 46% to $1.50 Thursday, the day after it reported that a Phase II clinical study for its drug MN-221 failed to show it was effective in treating certain symptoms of acute asthma attacks. ...
Source : marketwatch-com

MediciNova 4/23/2012

19:01 : MediciNova (MNOV) says it's received a Notice of Allowance from the Austra - MediciNova (MNOV) says it's received a Notice of Allowance from the Australian Government Patent Office for an application that covers the use of ibudilast for the treatment of multiple forms of chronic neuropathic pain. Ibudilast is ...
Source : seekingalpha-com
actualidad MediciNova -


Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Biotechnology

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts